Biopharmaceutical company.
H.R. 6, The 21st Century Cures Act and the Innovations Initiative. Issues concerning care for chronic disease patients. Issues related to corporate tax reform and the taxation of U.S. multinational corporations. S. 149, the Medical Device Access and Innovation Protection Act and H.R. 160, the Protect Medical Innovation Act, and issues related to repeal of the medical device tax. S. 1946, the Tax Relief Extension Act of 2015; H.R. 34, the Tax Increase Prevention and Real Estate Investment Act of 2015; H.R. 2029, Consolidated Appropriations Act, 2016, as they relate to the R&D credit, bonus depreciation, the CFC look-through rule and the medical device tax. Issues related to corporate mergers. H.R. 2570, Strengthening Medicare Advantage through Innovation and Transparency for Seniors; S. 275 / H.R. 605, the Medicare Home Infusion Site of Care Act of 2015 and issues related to reimbursement for infused drugs administered through DME. H.R. 3762, Restoring Americans' Healthcare Freedom Reconciliation Act of 2015, as it relates to the repeal of the medical device tax. H.R. 2029, Consolidated Appropriations Act, 2016, as it relates to the delay repeal of the medical device tax and reimbursement for infused drugs administered through DME. H.R. 1314, Bipartisan Budget Act of 2015.
HCR - Health Issues TAX - Taxation/Internal Revenue Code MMM - Medicare/Medicaid BUD - Budget/Appropriations
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
THE NICKLES GROUP, LLC
601 13th St. NW, Suite 250 N, Washington, DC, 20005, US
MARY BETH SAVARY TAYLOR EMILY PORTER RACHEL JONES HENSLER MARY BETH SAVARY TAYLOR EMILY PORTER MARY BETH SAVARY TAYLOR EMILY PORTER RACHEL JONES HENSLER MARY BETH SAVARY TAYLOR EMILY PORTER